These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 29775119)

  • 1. Effects of exercise in combination with autologous bone marrow stem cell transplantation for patients with type 1 diabetes.
    Mohamed MT; Embaby EA; Labib A; El-Husseiny M; Khamis H; El-Demery A; Shoukry MM
    Physiother Theory Pract; 2019 Dec; 35(12):1233-1242. PubMed ID: 29775119
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin-secreting adipose-derived mesenchymal stromal cells with bone marrow-derived hematopoietic stem cells from autologous and allogenic sources for type 1 diabetes mellitus.
    Thakkar UG; Trivedi HL; Vanikar AV; Dave SD
    Cytotherapy; 2015 Jul; 17(7):940-7. PubMed ID: 25869301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictive factors for prolonged remission after autologous hematopoietic stem cell transplantation in young patients with type 1 diabetes mellitus.
    Xiang H; Chen H; Li F; Liu J; Su Y; Hao L; Wang F; Wang Z; Zeng Q
    Cytotherapy; 2015 Nov; 17(11):1638-45. PubMed ID: 26318272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Umbilical Cord Mesenchymal Stromal Cell With Autologous Bone Marrow Cell Transplantation in Established Type 1 Diabetes: A Pilot Randomized Controlled Open-Label Clinical Study to Assess Safety and Impact on Insulin Secretion.
    Cai J; Wu Z; Xu X; Liao L; Chen J; Huang L; Wu W; Luo F; Wu C; Pugliese A; Pileggi A; Ricordi C; Tan J
    Diabetes Care; 2016 Jan; 39(1):149-57. PubMed ID: 26628416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. C-peptide levels and insulin independence following autologous nonmyeloablative hematopoietic stem cell transplantation in newly diagnosed type 1 diabetes mellitus.
    Couri CE; Oliveira MC; Stracieri AB; Moraes DA; Pieroni F; Barros GM; Madeira MI; Malmegrim KC; Foss-Freitas MC; Simões BP; Martinez EZ; Foss MC; Burt RK; Voltarelli JC
    JAMA; 2009 Apr; 301(15):1573-9. PubMed ID: 19366777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of autologous bone marrow-derived stem cell transplantation in patients with type 2 diabetes mellitus: a randomized placebo-controlled study.
    Bhansali A; Asokumar P; Walia R; Bhansali S; Gupta V; Jain A; Sachdeva N; Sharma RR; Marwaha N; Khandelwal N
    Cell Transplant; 2014; 23(9):1075-85. PubMed ID: 23561959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diabetes technology and treatments in the paediatric age group.
    Shalitin S; Peter Chase H
    Int J Clin Pract Suppl; 2011 Feb; (170):76-82. PubMed ID: 21323816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of persistent remission following initial recovery in patients with type 1 diabetes treated with autologous peripheral blood stem cell transplantation.
    Walicka M; Milczarczyk A; Snarski E; Jedynasty K; Halaburda K; Torosian T; Urbanowska E; Król M; Jędrzejczak WW; Franek E
    Diabetes Res Clin Pract; 2018 Sep; 143():357-363. PubMed ID: 30036612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autologous hematopoietic stem cell transplantation and conventional insulin therapy in the treatment of children with newly diagnosed type 1 diabetes: long term follow-up.
    Gu Y; Gong C; Peng X; Wei L; Su C; Qin M; Wang X; Li F
    Chin Med J (Engl); 2014; 127(14):2618-22. PubMed ID: 25043077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical benefits of autologous haematopoietic stem cell transplantation in type 1 diabetes patients.
    Gu B; Miao H; Zhang J; Hu J; Zhou W; Gu W; Wang W; Ning G
    Diabetes Metab; 2018 Sep; 44(4):341-345. PubMed ID: 29331269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autologous nonmyeloablative hematopoietic stem cell transplantation in new-onset type 1 diabetes: a multicenter analysis.
    D'Addio F; Valderrama Vasquez A; Ben Nasr M; Franek E; Zhu D; Li L; Ning G; Snarski E; Fiorina P
    Diabetes; 2014 Sep; 63(9):3041-6. PubMed ID: 24947362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined treatment of intrapancreatic autologous bone marrow stem cells and hyperbaric oxygen in type 2 diabetes mellitus.
    Estrada EJ; Valacchi F; Nicora E; Brieva S; Esteve C; Echevarria L; Froud T; Bernetti K; Cayetano SM; Velazquez O; Alejandro R; Ricordi C
    Cell Transplant; 2008; 17(12):1295-304. PubMed ID: 19364067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early immunotherapy using autologous adult stem cells reversed the effect of anti-pancreatic islets in recently diagnosed type 1 diabetes mellitus: preliminary results.
    Mesples A; Majeed N; Zhang Y; Hu X
    Med Sci Monit; 2013 Oct; 19():852-7. PubMed ID: 24121994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Do youth with type 1 diabetes exercise safely? A focus on patient practices and glycemic outcomes.
    Roberts AJ; Yi-Frazier JP; Aitken KE; Mitrovich CA; Pascual MF; Taplin CE
    Pediatr Diabetes; 2017 Aug; 18(5):367-375. PubMed ID: 27380934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autologous bone marrow derived stem cell therapy in patients with type 2 diabetes mellitus - defining adequate administration methods.
    Sood V; Bhansali A; Mittal BR; Singh B; Marwaha N; Jain A; Khandelwal N
    World J Diabetes; 2017 Jul; 8(7):381-389. PubMed ID: 28751962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Residual β-Cell Function Predicts Clinical Response After Autologous Hematopoietic Stem Cell Transplantation.
    Xiang H; Yang C; Xiang T; Wang Z; Ge X; Li F; Su Y; Chen H; Huang X; Zeng Q
    Stem Cells Transl Med; 2016 May; 5(5):651-7. PubMed ID: 27025691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mesenchymal stem cell transplantation in newly diagnosed type-1 diabetes patients: a phase I/II randomized placebo-controlled clinical trial.
    Izadi M; Sadr Hashemi Nejad A; Moazenchi M; Masoumi S; Rabbani A; Kompani F; Hedayati Asl AA; Abbasi Kakroodi F; Jaroughi N; Mohseni Meybodi MA; Setoodeh A; Abbasi F; Hosseini SE; Moeini Nia F; Salman Yazdi R; Navabi R; Hajizadeh-Saffar E; Baharvand H
    Stem Cell Res Ther; 2022 Jun; 13(1):264. PubMed ID: 35725652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-Term Insulin Independence in Type 1 Diabetes Mellitus Using a Simplified Autologous Stem Cell Transplant.
    Cantú-Rodríguez OG; Lavalle-González F; Herrera-Rojas MÁ; Jaime-Pérez JC; Hawing-Zárate JÁ; Gutiérrez-Aguirre CH; Mancias-Guerra C; González-Llano O; Zapata-Garrido A; Villarreal-Pérez JZ; Gómez-Almaguer D
    J Clin Endocrinol Metab; 2016 May; 101(5):2141-8. PubMed ID: 26859103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-density lipoprotein subspecies between patients with type 1 diabetes and type 2 diabetes without / with intensive insulin therapy.
    Fukui T; Hirano T
    Endocr J; 2012; 59(7):561-9. PubMed ID: 22504174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autologous hematopoietic stem cell transplantation for type 1 diabetes.
    Voltarelli JC; Couri CE; Stracieri AB; Oliveira MC; Moraes DA; Pieroni F; Barros GM; Madeira MI; Malmegrim KC; Foss-Freitas MC; Simões BP; Foss MC; Squiers E; Burt RK
    Ann N Y Acad Sci; 2008 Dec; 1150():220-9. PubMed ID: 19120300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.